Engineering Fundamentals in Life Science | |||
| Session 490 - Cardiovascular and Cancer (II) | |||
| This session will highlight engineering approaches to problems in cancer, cardiovascular and other diseases. Emphasis will be on studies of transport, cell and tissue mechanics, heat transfer, and kinetics applied specifically to the areas of tumor biology, metastasis, and the circulation. Topics may span length-scales from molecular to organismal physiology, involving computational and/or experimental methods. Sample topics include: - angiogenesis - atherosclerosis - cancer cell adhesion and migration - cancer cell signaling - intracellular metabolism - diabetes - gene therapies – novel therapeutic strategies - ischemia / reperfusion injury - models of tumor development - sickle cell disease - thrombosis/fibrinolysis - tumor pharmacokinetics and drug delivery. | |||
| Chair: | Neil S. Forbes | ||
| CoChair: | Edgar O'Rear III | ||
| 490a | Scaffold Mesh Size and Mechanical Properties and Their Effects on Tevg Outcome Dany Munoz-Pinto, Mariah Hahn | ||
| 490b | Inter-Domain Non-Covalent Interactions Stabilize the Solution Structure of Human Von Willebrand Factor Indrajeet Singh, Harish Shankaran, Mark E Beauharnois, Zhihua Xiao, Paschalis Alexandridis, Sriram Neelamegham | ||
| 490c | Characterization of Peptides Isolated from Bacterial Display Libraries Binding to Tumor Cell Surface Receptors Karen Y. Dane, Yimin Zhu, Patrick S. Daugherty | ||
| 490d | Targeting L-Methioninase to the Vasculature of Tumors Naveen R. Palwai, Xiao-Ping Zang, J. Thomas Pento, Roger G. Harrison | ||
| Break | |||
| 490e | Dendrimer-Based Nanodevices for Targeted Cancer Therapy Based on Mechanistic Understanding of Device Performance Sezen Gurdag, Rangaramanujam M. Kannan, Sarah Staples, Larry Matherly | ||
| 490f | The Role of Mesenchymal Bone Marrow-Derived Cells in Tumor Formation Michelle R. Dawson, Dan G. Duda, Rakesh K. Jain | ||
| 490g | Influence of Toxicity Effects on Model-Based Docetaxel Treatment Design Jeffry A. Florian Jr., Robert S. Parker | ||
See more of Food, Pharmaceutical & Bioengineering Division